Yasuda, Ikkoh
Suzuki, Motoi
Maeda, Haruka
Terada, Mayumi
Sando, Eiichiro
Ng, Chris Fook Sheng
Otomaru, Hirono
Yoshida, Lay-Myint
Morimoto, Konosuke
Funding for this research was provided by:
Pfizer Japan
Article History
Received: 10 June 2021
Accepted: 30 March 2022
First Online: 28 April 2022
Declarations
:
: This analysis was implemented under the following existing study: “The low carriage prevalence of pneumococcus among community-dwelling older people: A cross-sectional study in Japan”. The study was approved by the Ethical Review Board of the Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan, and the institutional review boards of each study facility. Written informed consent was obtained from all participants or their families.
: Not applicable.
: KM reports receiving speaker fees from Kyorin Pharma and MSD within three years. The salaries of KM and HM are paid by the collaboration project of Nagasaki University and Pfizer Inc. All other authors declare that they have no competing interests.